Quick answer
Some effects of prostate cancer radiotherapy appear or persist years after the sessions end. The most common are in the bowel, the bladder and erections, and severe long-term effects are uncommon.3 In the ProtecT trial, after 12 years, 12% of men treated with radiotherapy had leakage of stool, compared with 6% in the other groups.1 Blood in the urine, urethral narrowing and, more rarely, another cancer in the area are also part of the picture.6,7,8
Why effects appear late
Radiation is aimed at the prostate, but the bladder, the urethra and the rectum lie right against it and receive part of the dose. In the opening drawing, the beams cross at the prostate, and the dashed lines mark the base of the bladder and the front wall of the rectum.
Late effects come from this dose to the neighboring organs and can appear long after treatment. Urethral narrowing, for example, appeared at a median of 2.2 years after radiotherapy, and studies with longer follow-up found more cases.6
Bowel
- Leakage of stool. In ProtecT, a British randomized trial, 12% of men treated with radiotherapy and hormone therapy had leakage of stool at 12 years, compared with 6% of those who had surgery and those on monitoring.1
- Rectal bleeding. It can come back over the years, as can bleeding in the urine.3
- Tumors with a less favorable prognosis. In a US study of 2,445 men, radiotherapy with hormone therapy led to worse bowel function than surgery at 10 years.2
In the CHHiP trial, with 3,216 men, moderate or worse bowel effects (grade 2 or higher) added up to 11% to 14% at 5 years, depending on the dose schedule.4
Urine and bladder
- Urinating at night. In ProtecT, at 12 years, 48% of the radiotherapy group woke up two or more times a night to urinate, compared with 34% of those who had surgery and 47% of the monitoring group. Age also plays a part in this number.1
- Urine leakage. It was less common than after surgery: 3% to 8% used pads 7 to 12 years after radiotherapy, compared with 18% to 24% of those who had surgery.1
- Blood in the urine. In a US database of 274,865 men treated with radiotherapy, 17.7% had blood in the urine after treatment, and 2.8% were diagnosed with radiation cystitis, inflammation of the bladder caused by radiation. Obesity, smoking and diabetes were linked to more radiation cystitis.7
- Urethral narrowing. A review of 16,129 men found narrowing in 2.2%, at a median of 4 years: 1.5% after external beam radiotherapy, 1.9% after brachytherapy and 4.9% when the two were combined.6
Urinary obstruction and urethral narrowing are the most common severe urinary effects.3 In CHHiP, grade 2 or higher urinary effects added up to 7% to 12% at 5 years.4
Erections and hormones
In ProtecT, 7 years after treatment, 27% of men treated with radiotherapy had erections firm enough for intercourse, compared with 18% of those who had surgery and 30% of the monitoring group. By 12 years, all groups had reached low levels. Age also matters: the monitoring group had a gradual decline in erections over the years.1
In the 10-year US study, surgery did not lead to worse sexual function than radiotherapy. In tumors with a less favorable prognosis, radiotherapy with hormone therapy led to worse hormonal function.2
Another cancer in the area
A review of 21 observational studies compared men who did and did not have radiotherapy. After radiotherapy, the risk was higher for bladder cancer (about 1.7 times) and for colon and rectal cancer (about 1.8 times).8
Even so, the absolute rates were low. In the studies with the highest numbers, they reached 3.8% for the bladder, 4.2% for the colon and 1.2% for the rectum. The increase was seen with external beam radiotherapy, not with brachytherapy.8 An international review considers the data on this risk still mixed.3
The same review points to a higher risk of hip fracture after radiotherapy, and urinary and bowel fistulas are rare.3
What has changed with current techniques
Current techniques allow higher doses with little or no increase in side effects.3
- Fewer sessions. In CHHiP, 20 sessions had long-term effects similar to the traditional 37-session schedule.4 In the PACE-B trial, radiotherapy in 5 sessions was not inferior to longer schedules in controlling the cancer, with the same bowel effects and more grade 2 or higher urinary effects at 5 years (26.9% versus 18.3%).5
- Gel between the prostate and the rectum. In a randomized trial of 222 men, a gel placed before radiotherapy moved the rectum away from the prostate. At 3 years, grade 2 or higher rectal effects were 0% with the gel and 5.7% without it.9
What the sessions involve and the types of radiotherapy are covered in radiotherapy for prostate cancer.
When an effect appears
Many late effects can be treated, and the approach depends on the problem and how severe it is. In severe cases that do not improve, a procedure or reconstructive surgery may be needed.3
For radiation cystitis, the US database recorded cystoscopy procedures, for diagnosis or treatment, in 29.9% of cases and hyperbaric oxygen in 16.7%. Removal of the bladder was needed in 1.95%.7 Urethral narrowing can also be treated, as I explain in urethral stricture.
The consultation
I also see men who have already had radiotherapy, including when PSA starts to rise, in person or online, as I describe in second opinion. Blood in the urine, a weak stream, urine leakage or burning when urinating after radiotherapy should be checked, even if years have passed. If you are still choosing a treatment, the comparison is in surgery or radiotherapy.
When to see a urologist
- If blood has appeared in your urine after radiotherapy, even years later
- If your stream has become weak or you feel your bladder does not empty
- If urine leakage or a strong urge to urinate has started or got worse
- If your PSA has gone up after radiotherapy
- If you are still choosing between surgery and radiotherapy
Frequently asked questions
What are the long-term effects of prostate radiotherapy?+
The most common are in the bowel, such as leakage of stool and bleeding, in the bladder, such as urinating more often and blood in the urine, and in erections. Severe long-term effects are uncommon.3 In the ProtecT trial, after 12 years, 12% of men treated with radiotherapy had leakage of stool, compared with 6% in the other groups.1
How long after radiotherapy can effects appear?+
Some appear years after the sessions end. Urethral narrowing, for example, appeared at a median of 2.2 years, and studies with longer follow-up found more cases.6
Can radiotherapy cause blood in the urine years later?+
Yes. In a US database of more than 274,000 men treated with radiotherapy, 17.7% had blood in the urine after treatment, and 2.8% were diagnosed with radiation cystitis, inflammation of the bladder caused by radiation.7
Does prostate radiotherapy increase the risk of another cancer?+
Observational studies show a higher risk of bladder, colon and rectal cancer after external beam radiotherapy, but the absolute rates were low. Brachytherapy was not linked to this increase.8
Radiotherapy or surgery, which affects erections more?+
In ProtecT, 7 years later, 27% of men treated with radiotherapy and 18% of those who had surgery had erections firm enough for intercourse. By 12 years, both groups had reached low levels.1 In a 10-year US study, surgery did not lead to worse sexual function than radiotherapy.2
References
- Donovan JL, Hamdy FC, Lane JA, et al. Patient-Reported Outcomes 12 Years after Localized Prostate Cancer Treatment. NEJM Evid. 2023;2(4):EVIDoa2300018. PubMed
- Al Hussein Al Awamlh B, Wallis CJD, Penson DF, et al. Functional Outcomes After Localized Prostate Cancer Treatment. JAMA. 2024;331(4):302-317. PubMed
- Matta R, Chapple CR, Fisch M, et al. Pelvic Complications After Prostate Cancer Radiation Therapy and Their Management: An International Collaborative Narrative Review. Eur Urol. 2019;75(3):464-476. PubMed
- Dearnaley D, Syndikus I, Mossop H, et al. Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial. Lancet Oncol. 2016;17(8):1047-1060. PubMed
- van As N, Griffin C, Tree A, et al. Phase 3 Trial of Stereotactic Body Radiotherapy in Localized Prostate Cancer. N Engl J Med. 2024;391(15):1413-1425. PubMed
- Awad MA, Gaither TW, Osterberg EC, et al. Prostate cancer radiation and urethral strictures: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis. 2018;21(2):168-174. PubMed
- Bologna E, Licari LC, Franco A, et al. Incidence and Management of Radiation Cystitis After Pelvic Radiotherapy for Prostate Cancer: Analysis From a National Database. Urology. 2024;191:86-92. PubMed
- Wallis CJ, Mahar AL, Choo R, et al. Second malignancies after radiotherapy for prostate cancer: systematic review and meta-analysis. BMJ. 2016;352:i851. PubMed
- Hamstra DA, Mariados N, Sylvester J, et al. Continued Benefit to Rectal Separation for Prostate Radiation Therapy: Final Results of a Phase III Trial. Int J Radiat Oncol Biol Phys. 2017;97(5):976-985. PubMed
Would you like to talk about your case?
In the consultation, I go over your tests and your priorities.
Book a consultation
